Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the ELITE ventricular function substudy-Reference-Cited by-同舟云学术

Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the ELITE ventricular function substudy

Published:2000-06 Issue:6 Volume:139 Page:1081-1087
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Konstam Marvin A.,Patten Richard D.,Thomas Ignatious,Ramahi Tarik,La Bresh Kenneth,Goldman Steven,Lewis William,Gradman Alan,Self K.Stanley,Bittner Vera,Rand William,Kinan Debra,Smith John J.,Ford Tim,Segal Robert,Udelson James E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Role of angiotensin converting enzyme inhibitors in preventing left ventricular remodeling following myocardial infarction;Konstam;Eur Heart J,1995

2. Angiotensin II-forming pathways in normal and failing human hearts;Urata;Circ Res,1990

3. Divergent effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats;Taylor;J Cardiovasc Pharmacol,1998

4. Relative effects of α1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog;McDonald;Circulation,1994

5. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. I: effects on left ventricular performance and neurohormonal systems;Spinale;Circulation,1997

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis;Chinese Medical Journal;2024-05-28

2. ARNI Versus Perindopril for Remodeling in HFrEF. A Cohort Study;Journal of Cardiovascular Pharmacology and Therapeutics;2023-01

3. Reversibility of Cardiac Remodeling in Hypertensive Patients with Heart Failure;Updates in Hypertension and Cardiovascular Protection;2023

4. Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction;Clinical Drug Investigation;2022-06-20

5. Recovery from Left Ventricular Dysfunction;Cardiology in Review;2022-06-07